Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 08 Aug 2023 – 20 Aug 2026, limited by Kotak Quant Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Kotak Quant Fund | Nifty 500 |
|---|---|---|
| 08 Aug 2023 | ₹100.00 | ₹100.00 |
| 08 Nov 2023 | ₹106.03 | ₹101.83 |
| 09 Feb 2024 | ₹135.56 | ₹117.77 |
| 11 May 2024 | ₹137.91 | ₹120.77 |
| 11 Aug 2024 | ₹153.86 | ₹135.25 |
| 12 Nov 2024 | ₹147.18 | ₹131.75 |
| 12 Feb 2025 | ₹135.30 | ₹123.36 |
| 15 May 2025 | ₹143.74 | ₹134.45 |
| 16 Aug 2025 | ₹143.51 | ₹133.81 |
| 16 Nov 2025 | ₹151.23 | ₹140.63 |
| 16 Feb 2026 | ₹153.12 | ₹138.49 |
| 20 May 2026 | ₹147.19 | ₹133.21 |
| 20 Aug 2026 | ₹152.35 | ₹138.73 |
| Metric | Kotak Mahindra · Regular · IDCW NAV ₹15.27 Very High risk ★★★★☆ | Category median Sectoral/ Thematic · 248 funds |
|---|---|---|
| +3.62% | +3.54% | |
| +15.06% | +11.47% | |
| — | +9.70% | |
| — | +10.32% | |
| +14.89% | +9.15% | |
| +6.36% | — | |
| +15.06% | +12.10% | |
| — | +10.32% | |
| — | +8.80% | |
| Risk | ||
| 16.01% | 15.91% | |
| 0.54 | 0.25 | |
| 0.71 | 0.32 | |
| -22.39% | -26.14% | |
| Nifty 500 | — | |
| +3.00% | -0.04% | |
| 1.05 | 0.98 | |
| 113.8% | 98.3% | |
| 103.2% | 101.5% | |
| 2.36% | 2.38% | |
| ₹503.79Cr | ₹1,160Cr | |
| 0.50% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 164% | 42% | |
| Abhishek Bisen | — | |
| 08 Aug 2023 | — | |
| 77 | — | |
| 28.0% | — | |
| 4.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.